This was followed (72 h) by significant decreases in the expression of PTHrP, PPARγ, ADRP, and SP-B, accompanied by a significant increase in the expression of αSMA, the key molecular and functional marker for BPD. This evidence concerns the gene PLIN2 and bronchopulmonary dysplasia.